lactose has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, G; Li, Y; Ma, X; Ni, L; Sun, J; Xin, W; Zhang, D; Zhang, T; Zhang, X | 1 |
| Benndorf, G; Haux, D; Herzog, H; Kuechler, I; Sakowitz, O; Sarrafzadeh, A; Unterberg, A | 1 |
1 trial(s) available for lactose and Disease Exacerbation
| Article | Year |
|---|---|
Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis.
Topics: Acute Disease; Biomarkers; Brain; Cerebral Angiography; Demography; Disease Progression; Female; Glucose; Glutamic Acid; Glycerol; Humans; Lactose; Male; Microdialysis; Middle Aged; Monitoring, Physiologic; Nervous System Diseases; Paresis; Predictive Value of Tests; Prospective Studies; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vasospasm, Intracranial | 2003 |
1 other study(ies) available for lactose and Disease Exacerbation
| Article | Year |
|---|---|
Anti-inflammation effect of methyl salicylate 2-O-β-D-lactoside on adjuvant induced-arthritis rats and lipopolysaccharide (LPS)-treated murine macrophages RAW264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Disease Progression; Gaultheria; Humans; Interleukin-1beta; Lactose; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Salicylates; Tumor Necrosis Factor-alpha | 2015 |